ABSTRACT. Utilizing an easy and safe ~rocedure for fetal
Our knowledge of fetal hematology is limited due to the fact that most earlier studies were performed on aborted fetuses or under sampling conditions which may have altered hematological values. Moreover, only a few hematological values during gestation have been published (1). Having developed an easy and safe technique for fetal blood sampling, we selected retrospectively for this study 163 fetuses born healthy at full term delivery to establish reference fetal hematological values using standardized methods. To date no fetal loss or premature labor has been attributed to these fetal samplings.
Sampling procedure. The fetal sampling method has been described in detail previously (2, 3) . A real time ultrasound scanner (ATL MARK 111) was used to locate the umbilical cord insertion on the placenta and to determine the best route of access to it without fetal interposition. The transducer was then maintained immobile while, under aseptic conditions, local anesthesia was performed with 1 % xylocaine into the anterior abdominal wall at the chosen puncture site. No /3-mimetic drugs or other medication were used prior to the procedure. A 20-gauge spinal needle (10 or 13 cm long), filled with 0.129 M sodium citrate solution and fixed to a 2 ml disposable syringe containing 0.1 ml of this solution, was introduced into the plane of the ultrasound sector near the transducer. The needle tip emitted a clearly visible echo and its progress toward the insertion of the cord was followed on the scope. The vein of the cord was punctured about 1 cm from its insertion.
Immediately after the first d r o~ of blood was obtained, the syringe was replaced by a new one containing no additive. The blood sample was immediately transferred into special tubes containing adequate anticoagulant for biological studies. The duration of the entire procedure was less than 10 min in 90% of the cases, and the automated evaluations of hematological parameters were completed within 30 min.
Patients. We studied 409 pregnancies and 435 fetal blood samplings were camed out (26 repetitive samplings) with the approval of the ethics committee of the hospital, the medical expert panel, and the informed consent of the patients. The fetal samplings were conducted for the prenatal diagnosis of toxoplasmosis (285 cases), rubella (37 cases), or hemophilia (30 cases), for rapid fetal karyotyping (32 cases), or for diagnosis of other miscellaneous conditions (25 cases). Medical abortions of affected fetuses were performed in 5 1 cases. For this study, aimed at establishing hematological reference values, we obtained data from 163 fetuses born in good health at full term delivery, without intrauterine growth retardation, and sampled between 18 and 30 wk of gestation. Hematological data also were obtained from 63 mothers at the date of the fetal blood sampling; these women were selected because of the absence of iron and folate deficiencies. Their corresponding neonates also were studied (the cord blood was collected at delivery by direct puncture under aseptic conditions).
Biological investigations. Usually we obtained approximately 2 ml of blood and divided it into three aliquots: about 500 anticoagulated in lyophilised EDTA K2 from Sarstedt (ref. determined with a Coulter Counter S Plus 11. (6) . Figure 1 for a mother and her fetus at 20 Repetitive samplings were carried out on five pregnant women with the aim of examining the evolution of selected enzyme activities and myoglobin values relating to a possible prenatal diagnosis of muscular dystrophy. Figure 3 illustrates the evolution of the RBC and the MCV values for the five fetuses each X sampled three times or more during gestation. The results show a progressive increase of RBC in all the fetuses in good correlation with our normal hematological values during gestation (see Table  1 and Table 2 ).
RESULTS

Typical distribution curves for WBC, RBC, and PLT volumes are presented in
H b type was characterized in 125 samples: 45 (36%) individuals had carried a fraction of fetal H b with the IEF pattern of H b F Sardinia (775 Thr-136 Ala) (7); samples with a different chain mutation have been detected. In the complete group, no a variant was found, two cases of sickle cell trait and one case of H b E were noted. H b Bart's was suggested in 13 cases, but clearly seen in nine. Unfortunately, sample volumes were too small to allow precise quantitation. In only one case, H b Bart's elevation was accompanied by a microcytosis as defined in Table 2 . Table  5 
DISCUSSION
For the present study we utilized a Coulter S Plus 11, a very accurate instrument and well adapted to small volumes of blood and rapid identification of fetal blood by analysis of WBC and RBC volumes. Fetal bone marrow erythropoiesis begins between the 16th and 18th wk of gestation (8) as liver hematopoiesis (9) is challenged by hepatocyte proliferation (10) (11) (12) (13) . It has been noted that the changes in the number of circulating normoblasts between 10 and 18 wk is associated with a progressive maturation of these cells (10) . There is a diminution of the diameter and densification of the nucleus and more acidophilia. In our study, the number of late normoblasts markedly decreased (from 13 k 6 to 5 f 4%) during the 12-wk period of gestation studied. Our values are lower than previously reported (14) . The normoblasts had almost the same cytological feature throughout this period. In contrast, changes in RBC and H b levels were rather small. Maturation is demonstrated by a diminution of MCV and RDW, and by the moderate increase in H b A synthesis. Adult H b is sufficiently separated from either H b F or acetylated H b F by IEF (15) . Since acetylated H b F is a constant fraction of H b F (16, 17) , it is justified to follow the increase in H b A synthesis by the H b A/Hb F acetylated ratio (18) using IEF and gel scanning. Soine a.spcct.v of:fitu! diJ&rcn/iul collnt.s,fiom 18 l o 30 wk c!f'gcstution ($163 norma1fitllse.s (tnneun + SD) - = 51) ...... No cytological or quantitative changes were observed in platelets during the fetal period studied. This may indicate that mature megakaryocytopoiesis is completed before 18 wk and before bone marrow erythropoiesis has begun (19) . Interestingly, PLT were never below 150 x lOY/Iiter in normal fetuses. Neutrophils were very low and increased slightly from about 0.2 (20th wk) to 0.4 x 10Y/liter (30th wk). This pattern also is obvious in cases sequentially sampled and contrasts with the neutrophilia observed at birth. About half of the granulocytes are band forms throughout the studied period. This neutropenia also appears in the WBC volume distribution curve (Fig. 1) .
It can be interpreted either as a strong margination or, more likely, as the physiological initiation of granulopoiesis in the bone marrow ( 19) . Anatomophysiological data (8, 20) support the latter hypothesis. This observation also further supports the absence of maternal contamination.
Eosinophil and monocyte counts were relatively constant from the 18th to the 30th wk of gestation. Some fetal lymphocytes are larger (but vary considerably in size) with a cytoplasm more basophilic than typical lymphocytes. The absolute counts are relatively stable. These observations disagree with those previously reported (2 1, 22) .
Excluding the prenatal diagnosis of hemoglobinopathies, H b abnormalities are surprisingly numerous. The geographic origin of the foreign families was about 7% from North Africa, 2% from South East Asia, and 1% from black countries. In this population, two cases of H b S and one case of Hb E were detected by IEF (5) . In two children from B-thalassemic heterozygote mothers, the expression of H b A was lower than usual with a H b A/Hb Fac ratio below 0.5. This method already has been used for antenatal and neonatal diagnosis of 0-thalassemia (23, 24) . If this foreign population is withdrawn, the frequency of heterozygote and homozygote fetuses for H b F Sardinia is 36% for the French population. This is vely close to previous data for Caucasian newborns in the United States (25) and in the Netherlands (26) . H b Bart's was detected in a group of 13 fetuses. A severe microcytosis, (I I I F1 at 20 wk compared to our reference value: 134 + 9) was obvious in only one (a fetus of black African origin) of these cases. Extrapolating from reported (27) , this latter case might be an athalassemia trait. A surprising finding was the detection of three different y chain variants (2.3%). Other recent studies have permitted identification of a large number of such variants. which may be more frequent than previously thought (25) . In the small number of cases in which ferritin was evaluated, no large differences were seen between individuals of varying gestational age. We did not measure ferritin values in mothers the day of the samplings. However, our normal values in the newborn range from 95 to 350 @g/liter and from 5 to 30 in pregnant women at the 3rd trimester of pregnancy.
As indicated in Table 4 , blood factors VIlI and V are about 40% of the activity between 19 and 27 wk. Factors I1 and IX (vitamin K dependent) are lower (around 10%). We did not observe any significant increase of these parameters.
These data confirm the results in prenatal diagnosis of hemophilia (which is usually performed at the 18th wk of pregnancy) and the development of hemostasis in the human fetus (28, 29) .
In conclusion. it has been possible to establish normal hematological parameters for a large group of 163 fetuses over a 12-wk period (from the 18th to the 30th wk of gestation). In a few cases, we were able to obtain serial measurements of hematological values to assess fetal erythropoiesis. This work suggests that studies of selected aspects of human prenatal biology are possible without significant risk to the fetus from the 18th wk of gestation to birth. We have conducted 435 fetal blood samplings without accident by direct puncture of the umbilical cord under ultrasound. This procedure, already routinely used for prenatal diagnosis of hemophilia (31) , rubella (32) and toxoplasmosis (33) , could be applied to a wide range of new possibilities (34) , including the study of the transplacental passage of drugs (35, 36) , the administration of intrauterine therapy (37) , and possibly for fetal monitoring.
